![](/img/cover-not-exists.png)
Neutral 5-substituted 4-anilinoquinazolines as potent, orally active inhibitors of erbB2 receptor tyrosine kinase
Peter Ballard, Bernard C. Barlaam, Robert H. Bradbury, Allan Dishington, Laurent F.A. Hennequin, D. Mark Hickinson, Ian M. Hollingsworth, Jason G. Kettle, Teresa Klinowska, Donald J. Ogilvie, Stuart EVolume:
17
Year:
2007
Language:
english
Pages:
4
DOI:
10.1016/j.bmcl.2007.08.073
File:
PDF, 143 KB
english, 2007